Compare · OBIO vs RGC
OBIO vs RGC
Side-by-side comparison of Orchestra BioMed Holdings Inc. (OBIO) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OBIO and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.74B, about 8.5x OBIO ($322.2M).
- Over the past year, OBIO is up 79.3% and RGC is down 59.0% - OBIO leads by 138.3 points.
- OBIO has hit the wire 8 times in the past 4 weeks while RGC has been quiet.
- OBIO has more recent analyst coverage (9 ratings vs 0 for RGC).
PerformanceOBIO+79.26%RGC-59.04%
2025-08-26+0.00%2026-08-25
- Company
- Orchestra BioMed Holdings Inc.
- Regencell Bioscience Holdings Limited
- Price
- $5.36-1.65%
- $5.53+3.66%
- Market cap
- $322.2M
- $2.74B
- 1M return
- +40.68%
- -5.31%
- 1Y return
- +79.26%
- -59.04%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2021
- News (4w)
- 8
- 0
- Recent ratings
- 9
- 0
Latest OBIO
- Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
- Director Mack John Prosper covered exercise/tax liability with 4,885 shares, decreasing direct ownership by 7% to 66,544 units (SEC Form 4) (tax liability)
- Director Fain Eric S covered exercise/tax liability with 5,145 shares (SEC Form 4) (withholding obligation)
- Director Pacitti David covered exercise/tax liability with 3,761 shares, decreasing direct ownership by 6% to 54,750 units (SEC Form 4) to satisfy withholding tax
- Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
- SEC Form 10-Q filed by Orchestra BioMed Holdings Inc.
- Officer Sherman Darren sold $61,350 worth of shares (15,000 units at $4.09) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,154,327 units (SEC Form 4)
- SEC Form 144 filed by Orchestra BioMed Holdings Inc.
- Officer Sherman Darren sold $64,050 worth of shares (15,000 units at $4.27) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,169,327 units (SEC Form 4)
- SEC Form 144 filed by Orchestra BioMed Holdings Inc.
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited